En este registro encontrará las audiencias efectuadas en conformidad con la ley N° 20.730 por los sujetos pasivos que se señalan.
| Fecha | Identificador | Asistentes | Representados | Materia | Detalle | |
|---|---|---|---|---|---|---|
| 2026-02-17 10:30:00-03 | AC001AW2078492 | Sujeto Pasivo | Murad Barghouti | Durante la audiencia, sus representantes presentaron las características de su empresa y los productos que desean ofrecer al sistema de salud de Chile. Señalaron estar informados de los nuevos requerimientos que existen en Chile por trazabilidad de medicamentos e interconectividad de antecedentes de los pacientes. Al respecto se les señaló que Chile estaba abierto a las inversiones y negocios de Türkiye y que, en este sentido, debido a que se trata de ofertas comerciales y procesos de licitación debían tomar contacto con las autoridades centrales del Ministerio de Salud y sus agencias. Se les recomendó tomar contacto con la Directora de la Oficina Comercial de Chile en Estambul y con la agregada comercial de Türkiye en Santiago. Tiga Healthcare Technologies is a provider of national scale healthcare solutions. We are the key partners of the Turkish Government in the digitalization of the healthcare sector and we have developed the first pharmaceutical track and trace system in the world making the entire drug supply chain transparent and traceable preventing counterfeits and maximizing safety. Recently we came across a proposal for a decree amending supreme decree no. 3 of 2010 of the ministry of health which approves the regulations of the national system for the control of pharmaceutical products for human use of the ministry of health. On the fifth page the document proposes to amend article 72 to have digital traceability of medicine in the country. As the first company in the world to develop this national scale system for Turkey we would like to share our experience and expertise with Chile and we kindly ask for an opportunity to visit your embassy to provide more detailed information about the solutions we offer that would provide benefit and added value to your country. Below I would like to provide some information about our company Tiga is the first company in the world to develop an end to end pharmaceutical track and trace system in Turkey which has been characterized as a Best Practice in pharmaceutical track and trace in the world according to PricewaterhouseCoopers PwC Page 39 46. According to the UN report on Ensuring Supply Chain Security The Role of Anti Counterfeiting Technologies Turkey was able to save USD 1 billion of Government health expenditure by preventing tax fraud. Following the success in Turkey Tiga developed the track and trace systems in Saudi Arabia and Qatar. The track and trace system developed by Tiga can help Chile establish complete traceability of drugs control of the stocks prevention of counterfeits and guarantee that the drugs are in the right place at the right time. We are looking forward to share our experience with Chile. |
Ver Detalle | |
| 2026-02-05 10:30:00-03 | AC001AW2068313 | Sujeto Pasivo | Hasan Kocak | La audiencia correspondió a una reunión de cortesía de carácter institucional en el marco de la relación previamente existente orientada al fortalecimiento del diálogo y del relacionamiento bilateral. En la oportunidad se conversó respecto de los proyectos actualmente en ejecución, la próxima participación de ASELSAN en FIDAE 2026, así como la excelente vinculación institucional que ha desarrollado ASELSAN con entidades nacionales. |
Ver Detalle | |